KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $63.2 million.

  • Pacific Biosciences Of California's Total Current Liabilities rose 535.36% to $63.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.2 million, marking a year-over-year increase of 535.36%. This contributed to the annual value of $66.3 million for FY2024, which is 3023.29% down from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Total Current Liabilities is $63.2 million, which was up 535.36% from $59.8 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Total Current Liabilities registered a high of $271.4 million during Q2 2023, and its lowest value of $33.7 million during Q1 2021.
  • For the 5-year period, Pacific Biosciences Of California's Total Current Liabilities averaged around $104.2 million, with its median value being $71.7 million (2021).
  • In the last 5 years, Pacific Biosciences Of California's Total Current Liabilities crashed by 7443.66% in 2021 and then surged by 33545.98% in 2023.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Total Current Liabilities stood at $71.7 million in 2021, then soared by 267.23% to $263.3 million in 2022, then crashed by 63.91% to $95.0 million in 2023, then plummeted by 30.23% to $66.3 million in 2024, then decreased by 4.66% to $63.2 million in 2025.
  • Its Total Current Liabilities was $63.2 million in Q3 2025, compared to $59.8 million in Q2 2025 and $66.6 million in Q1 2025.